#1 Clinical Trials Search in Europe

Terlipressin

Terlipressin is a synthetic vasopressin analog that has been the subject of several clinical trials exploring its potential benefits in treating various medical conditions. This article examines the use of terlipressin in clinical trials for conditions such as portal hypertension, septic shock, hepatorenal syndrome, and surgical procedures like myomectomy. We’ll look at how terlipressin compares to other treatments and its effects on patient outcomes.

Table of Contents

What is Terlipressin?

Terlipressin is a medication that belongs to a class of drugs called vasopressin analogs. It is a synthetic version of a naturally occurring hormone in the body called vasopressin. Terlipressin is also known by the brand name Glypressin[1]. This medication is primarily used in medical settings to treat certain conditions related to liver disease and bleeding.

Medical Conditions Treated with Terlipressin

Terlipressin is used to treat several medical conditions, including:

  • Hepatorenal Syndrome (HRS): This is a serious kidney problem that can occur in people with advanced liver disease. Terlipressin is used to improve kidney function in patients with a specific type of HRS called HRS-AKI (Acute Kidney Injury)[2].
  • Variceal Bleeding: This is bleeding from enlarged veins in the esophagus or stomach, which can occur in patients with liver cirrhosis (scarring of the liver). Terlipressin is used to stop this type of bleeding[3].
  • Portal Hypertension: This is high blood pressure in the portal vein, which carries blood from the digestive organs to the liver. Terlipressin can help reduce this pressure[4].
  • Septic Shock: In some cases, terlipressin is used to treat severe septic shock that doesn’t respond to other treatments[1].

How Terlipressin Works

Terlipressin works by causing blood vessels to constrict or narrow. This action has several effects in the body:

  1. It increases blood pressure, which can be helpful in conditions where blood pressure is too low, such as in septic shock.
  2. In the case of hepatorenal syndrome, it helps improve blood flow to the kidneys, which can improve kidney function[2].
  3. For variceal bleeding, the constriction of blood vessels can help reduce bleeding from enlarged veins in the digestive tract[3].
  4. In portal hypertension, terlipressin can help reduce the pressure in the portal vein by constricting blood vessels in the digestive system[4].

Administration Methods

Terlipressin is typically administered in a hospital setting by healthcare professionals. It can be given in several ways:

  • Intravenous (IV) Bolus: This is a quick injection into a vein[4].
  • Continuous IV Infusion: The medication is given slowly and continuously through an IV line[2].
  • Intramyometrial Injection: In some surgical procedures, terlipressin may be injected directly into the muscle of the uterus to reduce bleeding[5].

The method of administration and dosage will depend on the specific condition being treated and the patient’s individual needs.

Clinical Trials and Research

Terlipressin is the subject of ongoing research to better understand its effects and potential uses. Some areas of current research include:

  • Comparing continuous infusion versus bolus injection of terlipressin for treating portal hypertension-related bleeding in liver cirrhosis[3].
  • Evaluating the use of terlipressin in liver transplant candidates with hepatorenal syndrome[2].
  • Investigating the effects of terlipressin on portal vein pressure in patients after liver tumor surgery[6].
  • Studying the use of terlipressin in managing potential organ donors to improve organ function for transplantation[7].

Side Effects and Precautions

Like all medications, terlipressin can cause side effects. Some potential side effects include:

  • Abdominal pain
  • Diarrhea
  • Headache
  • High blood pressure
  • Low sodium levels in the blood (hyponatremia)[3]

Terlipressin should only be used under close medical supervision. It’s important for patients to inform their healthcare providers about all medications they are taking and any existing medical conditions, especially heart or blood vessel problems.

In conclusion, terlipressin is a powerful medication used primarily in hospital settings to treat serious conditions related to liver disease and bleeding. While it can be very effective, it requires careful administration and monitoring by healthcare professionals.

Condition Terlipressin Use Key Findings
Portal Hypertension Intravenous bolus or continuous infusion Studied for effects on portal vein pressure after liver resection and in cirrhosis patients
Septic Shock Bolus injection or continuous infusion Compared bolus vs. continuous administration in refractory septic shock
Hepatorenal Syndrome Continuous infusion Evaluated for improving renal function in liver transplant candidates
Myomectomy Intramyometrial injection Compared to carbetocin for reducing blood loss during laparoscopic and open myomectomy
Organ Donor Management Continuous infusion Studied for hemodynamic stability in potential brain-dead organ donors

FAQ

  • What is terlipressin and how does it work? Terlipressin is a synthetic vasopressin analog that acts as a vasoconstrictor. It works by constricting blood vessels, particularly in the splanchnic (abdominal) area, which can help increase blood pressure and improve blood flow to vital organs.
  • In which medical conditions is terlipressin being studied? Terlipressin is being studied in various conditions, including portal hypertension, septic shock, hepatorenal syndrome, and as a means to reduce blood loss during surgical procedures like myomectomy.
  • How is terlipressin administered in clinical trials? Terlipressin administration varies depending on the study. It can be given as an intravenous bolus injection, continuous infusion, or as an intramyometrial injection during surgical procedures.
  • What are some potential benefits of using terlipressin? Potential benefits of terlipressin include reducing portal vein pressure in liver disease, improving renal function in hepatorenal syndrome, stabilizing blood pressure in septic shock, and decreasing blood loss during surgical procedures.
  • Are there any side effects or risks associated with terlipressin use? While specific side effects weren't detailed in the provided trial information, vasoconstrictor drugs like terlipressin can potentially cause adverse effects such as hypertension, bradycardia, or ischemia in some patients. Always consult with a healthcare professional for personalized medical advice.

Ongoing Clinical Trials on Terlipressin

  • Study on Tranexamic Acid and Terlipressin for Emergency Treatment of Mild to Severe Hemoptysis in Patients Without Cystic Fibrosis

    Not recruiting

    3 1 1
    Investigated drugs:
    France

Glossary

  • Terlipressin: A synthetic vasopressin analog that acts as a vasoconstrictor, used to treat various conditions related to low blood pressure or excessive bleeding.
  • Portal hypertension: Increased blood pressure in the portal vein system, often associated with liver disease.
  • Hepatorenal syndrome (HRS): A type of kidney failure that occurs in patients with advanced liver disease.
  • Septic shock: A life-threatening condition caused by a severe infection leading to low blood pressure and organ failure.
  • Myomectomy: A surgical procedure to remove uterine fibroids while preserving the uterus.
  • Splanchnic circulation: The blood flow to the digestive organs in the abdomen.
  • Vasoconstrictor: A substance that causes blood vessels to narrow, typically increasing blood pressure.
  • Intramyometrial: Within the muscular wall of the uterus.
  • Hemodynamic: Relating to the flow of blood within the body.
  • Hepatic venous pressure gradient (HVPG): A measure of portal hypertension, calculated as the difference between the wedged and free hepatic vein pressures.

References

  1. https://clinicaltrials.gov/study/NCT00793559
  2. https://clinicaltrials.gov/study/NCT04460560
  3. https://clinicaltrials.gov/study/NCT03130127
  4. https://clinicaltrials.gov/study/NCT04353193
  5. https://clinicaltrials.gov/study/NCT05154279
  6. https://clinicaltrials.gov/study/NCT03352349
  7. https://clinicaltrials.gov/study/NCT03477461